Transcription of CO-CODAMOL 30MG/500MG TABLETS PL …
{{id}} {{{paragraph}}}
MHRA-UKPAR CO-CODAMOL 30MG/500MG TABLETS PL 17907/0235 - 1 - CO-CODAMOL 30MG/500MG TABLETS PL 17907/0235 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 11 Steps taken after authorisation summary Page 12 Summary of Product Characteristics Page 13 Patient Information Leaflet Page 18 Labelling Page 20 MHRA-UKPAR CO-CODAMOL 30MG/500MG TABLETS PL 17907/0235 - 2 - CO-CODAMOL 30MG/500MG TABLETS PL 17907/0235 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency granted Bristol Laboratories Limited a Marketing Authorisation (licence) for the medicinal product CO-CODAMOL 30MG/500MG TABLETS (PL 17097/0235 on 23rd May 2011.)
MHRA-UKPAR – Co-codamol 30mg/500mg Tablets PL 17907/0235 -5 - PHARMACEUTICAL ASSESSMENT DRUG SUBSTANCE (1) Paracetamol INN: Paracetamol Ph Eur 500mg
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}